Women's Health Trial Tracker — 2013

Name: Women's Health Trial Tracker
Creator: 1 Women’s Health
License: United States government work; public domain unless the source record says otherwise.

Record	Record Date	Vuga Group	Change Status	Recency Days
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer	01/11/2013	INTERVENTIONAL	not-comparable	5,020.75
Group Interventions for Breast Cancer Survivors	01/24/2013	INTERVENTIONAL	not-comparable	5,007.75
Aldosterone & Sodium Regulation in Postural Tachycardia Syndrome - Screening	02/04/2013	INTERVENTIONAL	not-comparable	4,996.75
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma	02/11/2013	OBSERVATIONAL	not-comparable	4,989.75
A Prospective Cohort Study Evaluating Risk of Local Recurrence Following Breast Conserving Surgery and Endocrine Therapy in Low Risk Luminal A Breast Cancer	02/15/2013	OBSERVATIONAL	not-comparable	4,985.75
OTIS Cimzia Pregnancy Registry	02/22/2013	OBSERVATIONAL	not-comparable	4,978.75
Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis	02/26/2013	INTERVENTIONAL	not-comparable	4,974.75
Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With High Risk of Relapse, ER+ and HER2- Primary Breast Cancer, Free of Disease After Receiving at Least One Year of Adjuvant Hormone Therapy	03/06/2013	INTERVENTIONAL	not-comparable	4,966.75
Reproductive Health Program in Patients With Cancer	03/07/2013	INTERVENTIONAL	not-comparable	4,965.75
Elucidation of Breast Milk Composition and Structure Over the First Year of Lactation: UC Davis Lactation Study	03/22/2013	OBSERVATIONAL	not-comparable	4,950.75
The Efficacy and Safety of the Postoperative Adjuvant Treatment in Patients With High-risk Stage I Endometrial Carcinoma	03/29/2013	INTERVENTIONAL	not-comparable	4,943.75
The Safety of Ovarian Preservation in Stage IA Endometrial Carcinoma	03/29/2013	INTERVENTIONAL	not-comparable	4,943.75
Survivorship Care Planning in Improving the Quality of Life in Breast Cancer Survivors	04/05/2013	INTERVENTIONAL	not-comparable	4,936.75
A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)	04/05/2013	INTERVENTIONAL	not-comparable	4,936.75
Prospective Data Bank Creation to Study Vaginal Conditions	04/11/2013	OBSERVATIONAL	not-comparable	4,930.75
Breast Cancer Proteomics and Molecular Heterogeneity	04/25/2013	OBSERVATIONAL	not-comparable	4,916.75
Assessing Reproductive Outcomes in Young Female Cancer Survivors Through a National Fertility Preservation Registry	04/30/2013	OBSERVATIONAL	not-comparable	4,911.75
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.	05/03/2013	INTERVENTIONAL	not-comparable	4,908.75
Ovarian Tissue Transplantation	06/06/2013	INTERVENTIONAL	not-comparable	4,874.75
Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer	06/07/2013	INTERVENTIONAL	not-comparable	4,873.75
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery	06/07/2013	INTERVENTIONAL	not-comparable	4,873.75
Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy	06/11/2013	INTERVENTIONAL	not-comparable	4,869.75
An Optimized Programming of Healthy Children (APPROACH)	07/10/2013	INTERVENTIONAL	not-comparable	4,840.75
Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer	07/23/2013	INTERVENTIONAL	not-comparable	4,827.75
Prophylactic Salpingectomy With Delayed Oophorectomy	07/25/2013	INTERVENTIONAL	not-comparable	4,825.75
Randomized Controlled Trial to Assess Blockade of Voltage Gated Sodium Channels During Surgery in Operable Breast Cancer	08/05/2013	INTERVENTIONAL	not-comparable	4,814.75
Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast Cancer	08/26/2013	INTERVENTIONAL	not-comparable	4,793.75
Supervised Aerobic Training During or After Chemotherapy for Operable Breast Cancer	09/17/2013	INTERVENTIONAL	not-comparable	4,771.75
Endometriosis, Food Consumption and Fertility	09/20/2013	OBSERVATIONAL	not-comparable	4,768.75
Assessment of Paclitaxel-Induced Neuropathy	09/30/2013	OBSERVATIONAL	not-comparable	4,758.75
Muscle Fiber Fragment Treatment for Urinary Incontinence	09/30/2013	INTERVENTIONAL	not-comparable	4,758.75
Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery	10/01/2013	INTERVENTIONAL	not-comparable	4,757.75
SWIFT: Study of Women, Infant Feeding and Type 2 Diabetes After GDM Pregnancy	10/22/2013	OBSERVATIONAL	not-comparable	4,736.75
Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer	10/28/2013	INTERVENTIONAL	not-comparable	4,730.75
A Pilot Study Testing a Noninvasive Cryolipolysis Device Versus a High Intensity Focused Ultrasound Device for Fat Reduction	11/05/2013	INTERVENTIONAL	not-comparable	4,722.75
Predictive Clinical and Biological Parameters in Gynecological Cancer	11/06/2013	INTERVENTIONAL	not-comparable	4,721.75
REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy	11/14/2013	INTERVENTIONAL	not-comparable	4,713.75
Brain Functional MRI in Older Women With Breast Cancer (Brain fMRI-BC)	11/25/2013	OBSERVATIONAL	not-comparable	4,702.75
Fulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast Cancer	11/25/2013	INTERVENTIONAL	not-comparable	4,702.75
Chronic Toxicities Related to Treatment in Patients With Localized Cancer	11/25/2013	INTERVENTIONAL	not-comparable	4,702.75
FDG PET/CT in Breast Cancer Bone Mets	11/27/2013	OBSERVATIONAL	not-comparable	4,700.75
Levobupivacaine and Lidocaine for Paravertebral Block Causes Greater Hemodynamic Oscillations Than Levobupivacaine	12/09/2013	INTERVENTIONAL	not-comparable	4,688.75
Characterization of a Prospective Cohort of Women With PCOS	12/13/2013	OBSERVATIONAL	not-comparable	4,684.75